POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
47,22
21-февраля-25 16:30:01
15 мин. задержка
Акции
+0,72
+1,55%
Сегодняшний диапазон
46,86 - 48,81
ISIN
N/A
Источник
NYSE
- Котировки
- Графики
Новости
- Статистика
-
03 дек 2024 11:56:31 Источник NASDAQ Stocks
-
03 дек 2024 11:40:19 Источник NASDAQ US Markets
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
03 дек 2024 09:45:24 Источник NetDania Notify
-
POST Crosses Above Average Analyst Target
27 ноя 2024 08:15:52 Источник NASDAQ US Markets
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
15 ноя 2024 09:45:12 Источник NetDania Notify
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
13 ноя 2024 09:45:09 Источник NetDania Notify
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
12 ноя 2024 09:45:05 Источник NetDania Notify
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
11 ноя 2024 09:46:06 Источник NetDania Notify
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
08 ноя 2024 10:21:34 Источник NetDania Notify
-
NetDania - New 12 months Low: POSCO HOLDINGS INC. AMERICAN DEPOSITARY SHARES (EA
06 ноя 2024 09:46:52 Источник NetDania Notify
-
POST Factor-Based Stock Analysis - Peter Lynch
30 окт 2024 16:20:40 Источник NASDAQ US Markets
-
Gilead Sciences : Phase 3 Data Shows 96% Reduction In HIV Infections With Lenacapavir
07 окт 2024 21:59:05 Источник NASDAQ US Markets
-
POST Factor-Based Stock Analysis - Peter Lynch
02 окт 2024 16:21:13 Источник NASDAQ US Markets
-
Post Holdings Confirms Annual Adjusted EBITDA Outlook
25 сен 2024 08:57:18 Источник NASDAQ US Markets
-
Nippon Steel To Sell POSCO HD Shares
24 сен 2024 06:23:18 Источник NASDAQ US Markets
-
Post Holdings Up 13% in 3 Months: Should You Cash in or Stay Invested?
19 сен 2024 09:04:50 Источник NASDAQ Stocks
-
14 сен 2024 06:16:54 Источник NASDAQ Stocks
-
J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial
14 сен 2024 04:11:53 Источник NASDAQ US Markets
-
J&J : Phase 3 Data Show RYBREVANT + LAZCLUZE Outperforms Osimertinib In Non-small Cell Lung Cancer
08 сен 2024 23:23:17 Источник NASDAQ US Markets
-
POST Factor-Based Stock Analysis - Peter Lynch
04 сен 2024 14:16:57 Источник NASDAQ US Markets